Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele

References

• Cherian A, Seena S, Bullock RK, Antony AC. Incidence of neural tube defects in the least-developed area of India: a population-based study. Lancet 2005;366:930–1.
   PubMed Web of Science ®Google Scholar
• Lary JM, Edmonds LD. Prevalence of spina bifida at birth – United States, 1983–1990: a comparison of two surveillance systems. MMWR CDC Surveill Summ 1996;45:15–26.
   PubMedGoogle Scholar
• Au KS, Ashley-Koch A, Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev 2010;16:6–15.
   PubMed Web of Science ®Google Scholar
• Mendizabal S, Estornell F, Zamora I, Sabater A, García-Ibarra F, Simon J. Renal transplantation in children with severe bladder dysfunction. J Urol 2005;173:226–9.
   PubMed Web of Science ®Google Scholar
• Garat JM, Caffaratti J, Angerri O, Bujons A, Villavicencio H. Kidney transplants in patients with bladder augmentation: correlation and evolution. Int Urol Nephrol 2009;41:1–5.
   PubMed Web of Science ®Google Scholar
• Jachimiak B, Jarmoliński T. A child with myelomeningocele as a dialytic patient. Przegl Lek 2006;63:176–9.
   PubMedGoogle Scholar
• Müller T, Arbeiter K, Aufricht C. Renal function in meningomyelocele: risk factors, chronic renal failure, renal replacement therapy and transplantation. Curr Opin Urol 2002;12:479–84.
   PubMedGoogle Scholar
• Steers W. Potential targets in the treatment of urinary incontinence. Rev Urol 2001;3:19–26.
   Google Scholar
• Liu HT, Kuo HC. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol 2008;179:2270–4.
   PubMed Web of Science ®Google Scholar
• Kim JC, Park EY, Seo SI, Park YH, Hwang TK. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder syndrome. J Urol 2005;12:875–80.
   Web of Science ®Google Scholar
• Bonofiglio R, Antonucci MT, Papalia T, Romeo F, Capocasale G, Caroleo MC, et al. Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys. J Nephrol 2007;20:186–95.
   PubMed Web of Science ®Google Scholar
• Wakabayashi Y, Tomoyoshi T, Tooyama I, Kitahama K, Kim SU, Maeda T. Low-affinity nerve growth factor receptor immunoreactivity in the human urinary bladder. Neurosci Lett 1995;86:9–12.
   Google Scholar
• Tanner R, Chambers P, Khadra MH, Gillespie JI. The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro. BJU Int 2000;85:1115–19.
   PubMed Web of Science ®Google Scholar
• Liu HT, Kuo HC. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention. Neurourol Urodyn 2009;28:78–81.
   PubMed Web of Science ®Google Scholar
• Jang J, Park EY, Seo SI, Hwang TK, Kim JC. Effects of intravesical instillation of cyclooxygenase-2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide-induced overactive bladder. BJU Int 2006;98:435–9.
   PubMed Web of Science ®Google Scholar
• Liu HT, Kuo HC. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. J Urol 2008;72:104–8.
   Google Scholar
• Lamb K, Gebhart GF, Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J Pain 2004;5:150–6.
   PubMed Web of Science ®Google Scholar
• Zvara P, Vizzard MA. Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord. BMC Physiol 2007;28:7–9.
   Google Scholar
• Kuo HC, Liu HT, Chancellor MB. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence. Neurourol Urodyn 2009;29:482–7.
   Web of Science ®Google Scholar
• Yokoyama T, Kumon H, Nagai A. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Neurourol Urodyn 2008;27:417–20.
   PubMed Web of Science ®Google Scholar
• Bjorling DE, Jacobsen HE, Blum JR, Shih A, Beckman M, Wang ZY, et al. Intravesical Escherichia coli lipopolysaccharide stimulates an increase in bladder nerve growth factor. BJU Int 2001;87:697–702.
   PubMed Web of Science ®Google Scholar
• Liu HT, Chancellor MB, Kuo HC. Urinary nerve growth factor level could be a biomarker in the differential diagnosis of mixed urinary incontinence in women. BJU Int 2008;102:1440–4.
   PubMed Web of Science ®Google Scholar
• Starkman JS, Dmochowski RR. Urgency assessment in the evaluation of overactive bladder (OAB). Neurourol Urodyn 2008;27:13–21.
   PubMed Web of Science ®Google Scholar
• Liu HT, Tyagi P, Chancellor MB, Kuo HC. Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. BJU Int 2010;106:1681–5.
   PubMed Web of Science ®Google Scholar
• Liu HT, Chancellor MB, Kuo HC. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int 2009;103:1668–72.
   PubMed Web of Science ®Google Scholar
• Liu HT, Chancellor MB, Kuo HC. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 2009;56:700–6.
   PubMed Web of Science ®Google Scholar
• Grajda A, Kułaga Z, Gurzkowska B, Napieralska E, Litwin M. Regional differences in the prevalence of overweight, obesity and underweight among Polish children and adolescents. Med Wieku Rozwoj 2011;15:258–65.
   PubMedGoogle Scholar
• Birder LA, Wolf-Johston A, Griffiths D, Resnick NM. Role of urothelial nerve growth factor in human bladder function. Neurourol Urodyn 2007;26:405–9.
   PubMed Web of Science ®Google Scholar
• Birder LA, Wolf-Johnston AS, Chib MK, Buffington CA, Roppolo JR, Hanna-Mitchell AT. Beyond neurons: involvement of urothelial and glial cells in bladder function. Neurourol Urodyn 2010;29:88–96.
   PubMed Web of Science ®Google Scholar
• Eryildirim B, Tarhan F, Gul AE, Erbay E, Kuyumcuoglu U. Immunohistochemical analysis of low affinity nerve growth factor receptor in the human urinary bladder. Urol Int 2006;77:76–80.
   PubMed Web of Science ®Google Scholar